Former CEO concludes his tenure after 11 years

Jolt Capital, one of Europe’s leading deeptech investors, announced today that Pierre-Yves Frouin, the founder and former CEO of BioSerenity, has concluded his tenure, marking the final phase of the remarkable entrepreneurial journey he launched 11 years ago.

“Jolt extends its gratitude for Pierre-Yves’s forward thinking leadership and successful achievements since founding the company in 2014, pioneering neuroscience innovations that were rapidly adopted in ICUs,” said Jean Schmitt. “BioSerenity is well positioned for the future as a leader in neurology and AI applications in neuroscience. We deeply appreciate Pierre Yves’s unwavering commitment to success. Having now reached our first one million patients, we continue to expand our operations every day.”

“I want to sincerely thank Jolt Capital for their trust, partnership, and long term commitment to BioSerenity’s mission,” said Pierre Yves Frouin. “I’m proud of what we’ve achieved and confident that, under Jolt’s stewardship, BioSerenity will continue to grow and impact patients’ lives worldwide.”

[Paris, January 15, 2026]